Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Faster recovery? study tests two spinal numbing drugs for bladder exams

NCT ID NCT07664618

Symptom relief Sponsor: Helwan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two numbing medicines given via spinal injection for cystoscopy (a procedure to look inside the bladder). One hundred adults received either prilocaine or bupivacaine, plus fentanyl. The main goal was to see which drug allowed patients to recover and be discharged faster. Researchers also tracked side effects like low blood pressure, nausea, and itching.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
prilocaine and bupivacaine (spinal anesthetics)
What this could lead to
If prilocaine works better, patients could recover faster and go home sooner after cystoscopy.
What could go wrong
This is a small, completed study with 100 participants. Results may not apply to all patients or procedures, and both drugs have known side effects like low blood pressure or nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Apr 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age from 18 to 65 years. * Both Sexes. * American Society of Anesthesiologists (ASA) physical status I-II. * Normal body mass index (BMI) 18-25. * Undergoing cystoscopic procedure under spinal anesthesia. Exclusion Criteria: * \- Patient's refusal. * History of allergy to local anesthetics (hyperbaric prilocaine or hyperbaric bupivacaine). * History of impaired gait before the study. * Contraindications to SA including :- * Coagulopathy. * Elevated intracranial pressure (ICP). * Infection at the site. * Spinal cord disorder. * Severe hypovolemia. * Uncontrolled hypertension systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg. * Uncontrolled Diabetes mellitus HbA1c ≥ 8.5%

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cystoscopic procedures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cystoscopic procedures Hyperbaric bupivacaine Hyperbaric prilocaine Intrathecal injection

Contacts and locations

Locations

  • Helwan University

    Helwan, 11795, Egypt